car health through with city of hope, one of the largest cancer research and treatment organizations in the United States. Carrum Health, which first launched on the East Coast last year, now offers a comprehensive, fixed-price package for the first non-metastatic breast cancer treatment, including a two-year warranty on care, at City of Hope facilities throughout Southern California. This includes more than 35 convenient locations, including the newly opened City of Hope Orange County Lennar Foundation Cancer Center.
“Cancer treatment has historically not been included in bundled payments due to lengthy treatment times and complex cases. But we know that for self-insured employers trying to cope with rising health care costs and provide their employees with the best quality of care, they is the primary consideration,” said Sach Jain, CEO and founder of Carrum Health. “Carrum Health alleviates these concerns with the only value-based bundled payment plan for oncology. Since launching the industry’s first comprehensive cancer care package last year, we have seen significant demand from employers looking to provide their employees with access to top cancer specialists closer to home. We are proud to partner with City of Hope to make this a reality.”
With Carrum Health’s bundled cancer care packages, patients with non-metastatic breast cancer may be eligible for up to two years of treatment at City of Hope, including resection surgery, chemotherapy, radiation therapy, care for treatment-related complications As well as interdisciplinary examinations – ins and follow-ups.
What is a super app? Super apps are not built to do one thing well, but to launch many products in a standalone environment. The Wall Street Journal recently published an article titled What is a “super app”? Why are Elon Musk, Evan Spiegel and Jack Dorsey so interested? Provide a description of WeChat, the super-app for Chinese internet companies:
“It started as a cross between a messaging app and social media, but has grown to cover everything from ride-hailing and e-commerce to mobile payments and government services. Today, it has nearly 1.3 billion users.”
In a recent blog post, Beth Strohbusch, Equivalentof “What will a healthcare super-app look like?” asked the head of marketing
Strohbusch acknowledges that digital health innovations bring value to consumers and clinicians, but “there are too many options today,” she said.
According to the 2021 Trends Report from the IQVIA Institute for Human Data ScienceIn 2020, more than 90,000 digital wellness apps were added to the app store — an average of over 250 a day. Apps that focus on managing a specific disease or health condition rather than health management accounted for 47% of apps, compared to 28% in 2015.
In healthcare, widespread adoption of single-use apps and devices is neither realistic nor sustainable. Equiva offers a new “super app type” approach through its point solution aggregation and software delivery environment that securely supports any number of educational and engagement solutions via mobile devices, kiosks, digital signage, and more.
Nursing feedCompany providing secure, cloud-based, HIPAA-compliant digital communications solutions, closed a $3 million financing round led by Reformation Partners. Existing investors Allos Ventures and M25 also participated in the round. This investment enables Carefeed to accelerate adoption of its platform by skilled nursing and senior living communities in the U.S. and Canada, expand its suite of solutions, and expand into other patient care settings.
To read more information, Click here.
Brain Examination Company., developer of an innovative digital cognitive assessment and care platform, announced an investigator-initiated research grant program to help fund research into the assessment, diagnosis, treatment and care of brain-related disorders. Diseases of interest include: Alzheimer’s disease and related dementias, postoperative delirium, stroke, traumatic brain injury and acute post-Covid “brain fog”. Winners will receive one year of research funding and free access to the BrainCheck platform.
To read more information, Click here.
immunization companyThe biotech startup developing a new treatment for age- and disease-related immune decline has raised $10 million as part of a Series A funding round. Remiges Ventures led the round with participation from several other healthcare investment firms. Proceeds will be used to support clinical evaluation of Immunis’ immunomodulatory secretome products in a Phase 1/2a clinical trial targeting muscle wasting, an age, disuse and disease-related condition.
To read more information, Click here.
atropos health, Providing research-grade real-world evidence to physicians, the company announced the close of a $14 million Series A funding round. The company will use the funds to expand its commercial team and continue to develop its oncology products. Breyer Capital led the round with participation from Emerson Collective and Boston Millennia Partners.
As part of this funding round, Atropos has appointed Matt Bettonville of Emerson Collective to the Atropos Health board of directors. Breyer Capital also got a board seat.
To read more information, Click here.
picture: Arkindo, Getty Images
